These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6542462)

  • 41. Protective effects of a novel nonglucocorticoid 21-aminosteroid (U74006F) during traumatic shock in rats.
    Aoki N; Lefer AM
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):205-10. PubMed ID: 1689414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Arachidonic acid metabolites and shock].
    Förster W
    Z Gesamte Inn Med; 1985 Apr; 40(8):217-21. PubMed ID: 3925652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Canale P; Squadrito F; Altavilla D; Ioculano M; Campo GM; Squadrito G; Urna G; Sardella A; Caputi AP
    Pharmacology; 1994 Dec; 49(6):376-85. PubMed ID: 7878075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of ethylketocyclazocine in hemorrhagic shock.
    Curtis MT; Lefer AM
    Adv Shock Res; 1983; 10():101-9. PubMed ID: 6308972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction in myocardial neutrophil accumulation and infarct size following administration of thromboxane inhibitor U-63,557A.
    Wargovich TJ; Mehta J; Nichols WW; Ward MB; Lawson D; Franzini D; Conti CR
    Am Heart J; 1987 Nov; 114(5):1078-85. PubMed ID: 2960223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiplatelet effect of a new inhibitor of thromboxane synthase and thromboxane A2 receptors.
    Tubaro E; Belogi L; Mezzadri CM
    Arzneimittelforschung; 1996 Jan; 46(1):35-41. PubMed ID: 8821515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock.
    Bitterman H; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):341-7. PubMed ID: 3116357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
    J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effect of cloricromene, a coumarine derivative, in hypovolemic hemorrhagic shock in the rat.
    Sturniolo R; Squadrito F; Campo GM; Vinci R; Calatroni A; Prosdocimi M; Caputi AP
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):261-6. PubMed ID: 1709231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Local renal ischemia during burn shock in rat effected by thromboxane A2 and serotonin.
    Haugan A; Kirkebø A
    Circ Shock; 1986; 20(1):13-23. PubMed ID: 3021355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism of the protective effect of conditioning in rats subjected to Noble-Collip drum trauma.
    Galvin MJ; Sollott SJ; Lefer AM
    Circ Shock; 1979; 6(1):23-9. PubMed ID: 455590
    [No Abstract]   [Full Text] [Related]  

  • 52. Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats.
    Furlan LE; Johnson G; Siegfried M; Lefer AM
    J Pharmacol Exp Ther; 1990 May; 253(2):525-9. PubMed ID: 2140129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beneficial actions of a free radical scavenger in traumatic shock and myocardial ischemia.
    Lefer AM; Araki H; Okamatsu S
    Circ Shock; 1981; 8(3):273-82. PubMed ID: 7249259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase.
    Tyler HM; Saxton CA; Parry MJ
    Lancet; 1981 Mar; 1(8221):629-32. PubMed ID: 6110861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective thromboxane synthetase inhibitor and ischemic heart disease.
    Ito T; Ogawa K; Watanabe J; Chen LS; Shikano M; Imaizumi M; Shibata T; Ito Y; Miyazaki Y; Satake T
    Biomed Biochim Acta; 1984; 43(8-9):S125-32. PubMed ID: 6542777
    [No Abstract]   [Full Text] [Related]  

  • 56. Protective effects of a novel 21-aminosteroid during splanchnic artery occlusion shock.
    Johnson G; Lefer AM
    Circ Shock; 1990 Feb; 30(2):155-64. PubMed ID: 2311204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of platelet-activating factor during traumatic shock.
    Stahl GL; Craft DV; Lento PH; Lefer AM
    Circ Shock; 1988 Nov; 26(3):237-44. PubMed ID: 3208421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beneficial actions of prostacyclin in traumatic shock.
    Lefer AM; Sollott SL; Galvin MJ
    Prostaglandins; 1979 May; 17(5):761-7. PubMed ID: 386429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
    Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
    Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective action of 6-keto-prostaglandin E1 in traumatic shock.
    Araki H; Lefer AM
    Prostaglandins Med; 1979 Apr; 2(4):277-84. PubMed ID: 575862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.